UBS analyst Brian Meredith raised the firm’s price target on Axis Capital to $85 from $82 and keeps a Buy rating on the shares. The macro environment continues to support good fundamentals for the life insurers and the firm expects P&C earnings to reflect strong fundamentals with some caution in results from uncertain “tort” inflation, the analyst tells investors in a set of preview notes.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXS:
Questions or Comments about the article? Write to editor@tipranks.com